Abzena
The MSAT Engineer at Abzena provides technical leadership and supports technology transfer activities from Process Development to GMP Manufacturing. The role serves as the technical bridge between process development and manufacturing, ensuring successful technology transfer, manufacturing readiness, and sustained process robustness for highly potent and complex biologic drug conjugates. The position involves supporting development-to-clinical cGMP manufacturing operations for bioconjugation processes, including ADCs and AOCs.
Abzena is a fully integrated biopharmaceutical CDMO+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Abzena.
Abzena didn’t post a salary, so this is our estimate from similar listings.
Process Development Senior Scientist - Synthetic Peptides, Oligonucleotides, ADCs
Amgen
Scientist, Vaccines and Advanced Biotechnologies (VAX) Process R&D
MSD
Scientist – Downstream Vaccines and Advanced Biotechnologies Process R&D
Merck & Co., Inc.
Scientist – Downstream Vaccines and Advanced Biotechnologies Process R&D
MSD
Advisor/Sr. Advisor - Bioconjugation Scientist
Eli Lilly and Company
Post-Doctoral Scientist, Bioconjugation Process Innovation
Eli Lilly and Company